References
- Amato GM, Travia A, Ziino O. The use of intravenous high-dose immunoglobulins (IVIG) in a case of Stevens–Johnson syndrome. Pediatr. Med. Chir.14, 555–556 (1992).
- Viard I, Wehrli P, Bullani R et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science282, 490–493 (1998).
- Stiehm ER. Human intravenous immunoglobulin in primary and secondary antibody deficiencies. Pediatr. Infect. Dis. J.16(7), 696–707 (1997).
- Prins C, Kerdel FA, Padilla RS et al. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch. Dermatol.139, 26–32 (2003).
- Metry DW, Jung P, Levy ML. Use of intravenous immunoglobulin in children with Stevens–Johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature. Pediatrics112, 1430–1436 (2003).
- Yeung CK, Lam LK, Chan HH. The timing of intravenous immunoglobulin therapy in Stevens–Johnson syndrome and toxic epidermal necrolysis. Clin. Exp. Dermatol.30, 578–602 (2005).
- Samimi SS, Siegfried E. Stevens–Johnson syndrome developing in a girl with systemic lupus erythematosus on high-dose corticosteroid therapy. Pediatr. Dermatol.19, 52–55 (2002).
- Lam NS, Yang YH, Wang LC, Lin YT, Chiang BL. Clinical characteristics of childhood erythema multiforme, Stevens–Johnson syndrome and toxic epidermal necrolysis in Taiwanese children. J. Microbiol. Immunol. Infect.37, 366–370 (2004).
- Arca E, Kose O, Erbil AH, Nisanci M, Akar A, Gur AR. A 2-year-old girl with Stevens–Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin. Pediatr. Dermatol.22, 317–320 (2005).
- Hebert AA, Bogle MA. Intravenous immunoglobulin prophylaxis for recurrent Stevens–Johnson syndrome. J. Am. Acad. Dermatol.50, 286–288 (2004).
- Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N. Engl. J. Med.345(10), 747–755 (2001).
- Young PK, Ruggeri SY, Galbraith S, Drolet BA. Vesicular eczema after intravenous immunoglobulin therapy for treatment of Stevens–Johnson syndrome. Arch. Dermatol.142(2), 247–248 (2006).